Analysts Set Inozyme Pharma, Inc. (NASDAQ:INZY) Target Price at $18.33
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine brokerages that are covering the company, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have issued ratings on the stock in the […]
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine brokerages that are covering the company, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have issued ratings on the stock in the […]
